Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 900.00K | £ 2.50M | £ 6.50M | £ 11.70M | £ 18.90M |
Total Assets | £ 514.80M | £ 485.70M | £ 463.80M | £ 439.90M | £ 453.80M |
Total Debt | £ 170.30M | £ 146.70M | £ 125.30M | £ 110.70M | £ 143.50M |
Net Debt | £ 169.40M | £ 144.20M | £ 118.80M | £ 99.00M | £ 124.60M |
Total Liabilities | £ 293.00M | £ 259.30M | £ 240.90M | £ 220.70M | £ 243.70M |
Stockholders Equity | £ 221.80M | £ 226.40M | £ 222.90M | £ 219.20M | £ 210.10M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |